1. Introduction {#Sec1}
===============

Although the incidence of pyogenic liver abscesses was considered rare in the past, the condition, related to underlying hepatobiliary diseases and polymicrobial infection, often leads to severe illness and death.\[[@CR1]\] Recently, primary liver abscesses (or cryptogenic liver abscesses), without any underlying hepatobiliary diseases, have been considered as pyogenic liver abscesses. \[[@CR2], [@CR3]\] However, Klebsiella pneumoniae has been indicated to be the first most common pathogen to the development of pyogenic liver abscesses, with Escherichia coli as the second most common pathogen. Diabetes, biliary disease, renal diseases, and cancers have been found to be the high predisposing comorbidities for pyogenic liver abscess. Chronic kidney disease and diabetes are definitely known to result in a compromised immune system and are considered to be risk factors for some infectious diseases.\[[@CR4], [@CR5]\]

The cause of herpes zoster is known to be the reactivation of the varicella-zoster virus, which occurs in cases of declined cellmediated immunity. Less than 5% of the population will be attacked by a second episode of herpes zoster, and second episodes that do occur frequently do so more in immune-compromised populations, like the aged, those with chronic renal disease, diabetes, malignancies, organ transplantation, or HIV infection.\[[@CR6], [@CR7]\] So we supposed that herpes zoster might be related to pyogenic liver abscessed. In the study, then, we used data gathered by the Taiwan National Health Insurance (NHI) program to clarify the relationship between herpes zoster and pyogenic liver abscess.

2. Methods {#Sec2}
==========

2.1. Study design and population {#Sec3}
--------------------------------

We conducted a nationwide cohort study using the database of the Taiwan National Health Insurance Program. The program began in March 1995 and covers almost 99% of the 23 million residents living in Taiwan.\[[@CR8]\] The details of the program can be found in previous high-quality studies.\[[@CR9]-[@CR13]\] The study was approved by the Institutional Review Board (IRB) of China Medical University and Hospital in Taiwan (CMUH-104-REC2-115).

2.2. Study participants {#Sec4}
-----------------------

We identified subjects aged 20-84 years with newly-diagnosed herpes zoster during the period of 1998-2010 as the herpes zoster group, based on the International Classification of Diseases 9th Revision (ICD-9 code 053). The date of herpes zoster diagnosis was defined as the index date. For each subject with herpes zoster, four comparison subjects without herpes zoster were randomly selected from the same NHI database as the non-herpes zoster group. The non-herpes zoster subjects were matched with the herpes zoster subjects by sex, age (every 5-year span), comorbidities, and the index year of the herpes zoster diagnosis. Subjects with history of pyogenic liver abscesses (ICD-9 code 572.0), amebic liver abscesses (ICD-9 code 006.3), or liver transplantation (ICD-9 codes 996.82 and V42.7) before the index date were excluded from this study.

2.3. Potential comorbidities and main outcome measurement {#Sec5}
---------------------------------------------------------

Comorbidities potentially associated with pyogenic liver abscesses were selected in the study as follows: alcohol-related diseases (ICD-9 codes 291, 303, 305.00, 305.01, 305.02, 305.03, 571.0- 571.3, 790.3 and V11.3), biliary stones (ICD-9 code 574), chronic kidney diseases (ICD-9 codes 585--586 and 588.8--588.9), cancers (ICD-9 codes 140-208), diabetes mellitus (ICD-9 code 250), as well as chronic liver diseases (including cirrhosis (ICD-9 codes 571.5 and 571.6), Hepatitis B (ICD-9 codes V02.61, 070.20, 070.22, 070.30 and 070.32), Hepatitis C (ICD-9 codes V02.62, 070.41, 070.44, 070.51 and 070.54) and other chronic hepatitis (ICD-9 codes 571.40, 571.41, 571.49, 571.8 and 571.9).

The main outcome was a new primary diagnosis of pyogenic liver abscesses based on hospital discharge registries during the follow-up periods of subjects. Each subject was monitored from their index date until they were diagnosed with pyogenic liver abscesses, or else they had to be censored because of a failure of the subject to follow-up, death, their withdrawal from insurance, or the end of the period of study (December 31, 2011).

2.4. Statistical analysis {#Sec6}
-------------------------

The distributions of sex, age, and other comorbidities were compared between the herpes zoster group and the non-herpes zoster group using a *Chi*-square test for categorized variables and a t-test for continuous variables. The incidence of pyogenic liver abscesses was estimated as the number of pyogenic liver abscesses events identified during the follow-up period, divided by the total follow-up person-years for each group. Initially, we included all variables in our univariable Cox proportional hazards regression model. Those found to be significant in the univariable model were further included in our multivariable Cox proportional hazards regression model to estimate the hazard ratio (HR) and 95 % confidence interval (CI) of the pyogenic liver abscesses risk associated with herpes zoster and other comorbidities. The statistical significance level was set to a two-sided probability value & 0.05. All analyses were performed using SAS software version 9.2 (SAS Institute Inc., Cary, North Carolina, USA).

3. Results {#Sec7}
==========

3.1. Baseline characteristics of the study population {#Sec8}
-----------------------------------------------------

Table [1](#Tab1){ref-type="table"} reveals the baseline characteristics between the herpes zoster group and the non-herpes zoster group. There were 33049 subjects in the herpes zoster group and 131707 subjects in the non-herpes zoster group, with similar distributions of sex and age. The mean ages (standard deviation) of the study subjects were 54.8 ±16.2 years for the herpes zoster group and 54.3 ± 16.3 for the non-herpes zoster group. The mean follow-up periods (standard deviation) were 5.68 ± 3.33 years in the herpes zoster group and 5.64 ± 3.32 years in the non-herpes zoster group. No significant difference was noted regarding the distribution of other comorbidities between the herpes zoster group and the non-herpes zoster group (*P* \> 0.05 for all).

3.2. Incidence of pyogenic liver abscesses in the study population {#Sec9}
------------------------------------------------------------------

The follow-up results revealed that the overall incidence of pyogenic liver abscesses was 1.38-fold greater in the herpes zoster group than in the non-herpes zoster group (4.47 *vs.* 3.25 per 10000 person-years, 95% CI 1.32, 1.44). Because no subject developed pyogenic liver abscesses among the herpes zoster group that was aged 20-39 years, subjects aged 20-39 years and aged 40- 64 years were merged into a single cohort of subjects aged 20-64 years. The incidence rates of pyogenic liver abscesses, as stratified by sex, age and follow-up period, were all higher in the herpes zoster group than those in the non-herpes zoster group. The herpes zoster group aged 65-84 years had the highest incidence rate of pyogenic liver abscesses (8.38 per 10000 person-years). The analysis as stratified by the follow-up periods revealed that the risk of pyogenic liver abscesses persisted over time, even one year after herpes zoster diagnosis (Table [2](#Tab2){ref-type="table"}).

3.3. Pyogenic liver abscesses associated with herpes zoster and other comorbidities {#Sec10}
-----------------------------------------------------------------------------------

After controlling for potential confounding factors, our multivariable Cox proportional hazards regression model revealed that the adjusted HR of pyogenic liver abscesses was 1.34 (95% CI 1.05, 1.72) for the herpes zoster group, when compared with the nonherpes zoster group. Sex (in this case male) (adjusted HR 1.41, 95% CI 1.13, 1.75), age (per one year, adjusted HR 1.03, 95% CI 1.02, 1.04), biliary stones (adjusted HR 2.87, 95% CI 2.03, 4.06), chronic kidney diseases (adjusted HR 2.41, 95% CI 1.60, 3.63), chronic liver diseases (adjusted HR 1.31, 95% CI 1.01, 1.71), cancers (adjusted HR 1.60, 95% CI 1.02, 2.53), and diabetes mellitus (adjusted HR 1.66, 95% CI 1.30, 2.12) were also significantly associated with pyogenic liver abscesses (Table [3](#Tab3){ref-type="table"}).

                                                      Non-herpes zoster N = 131707   Herpes zoster N = 33049                  
  --------------------------------------------------- ------------------------------ ------------------------- ------- ------ -------
  Sex                                                                                                                         0.94
  Female                                              69710                          52.9                      17500   53.0   
  Male                                                61997                          47.1                      15549   47.1   
  Age group (year)                                    0.92                                                                    
  20-39                                               26484                          20.1                      6625    20.1   
  40-64                                               65560                          49.8                      16434   49.7   
  65-84                                               39663                          30.1                      9990    30.2   
  Age (year), mean (standard deviation)†              54.3                           16.3                      54.8    16.2   0.001
  Follow-up time (year), mean (standard deviation)†   5.64                           3.32                      5.68    3.33   0.02
  Baseline comorbidities                                                                                                      
  Alcohol-related diseases                            4184                           3.18                      1111    3.36   0.09
  Biliary stones                                      4572                           3.47                      1210    3.66   0.09
  Chronic kidney diseases                             3699                           2.81                      986     2.98   0.09
  Chronic liver diseases                              23343                          17.7                      5906    17.9   0.53
  Cancers                                             5818                           4.42                      1521    4.60   0.15
  Diabetes mellitus                                   23589                          17.9                      5967    18.1   0.54

Data are presented as the number of subjects in each group with percentages given to their right, or the mean with the standard deviation given to the right.

\**Chi*-square test and †*t-test* comparing subjects with and without herpes zoster.

                     Non-herpes zoster   Herpes zoster                                                
  ------------------ ------------------- --------------- -------- ------ ------- ---- -------- ------ -------------------
  All                131707              241             742588   3.25   33049   84   187870   4.47   1.38 (1.32, 1.44)
  Sex                                                                                                 
  Female             69710               109             398992   2.73   17500   39   100678   3.87   1.42 (1.34, 1.50)
  Male               61997               132             343596   3.84   15549   45   87192    5.16   1.34 (1.27, 1.43)
  Age group (year)                                                                                    
  20-64\*\*          992044              134             537146   2.49   23059   40   135360   2.96   1.18 (1.12, 1.25)
  65-84              39663               107             205442   5.21   9990    44   52510    8.38   1.61 (1.50, 1.73)
  Follow-up period                                                                                    
  ≤ 6 months         131707              20              65489    3.05   33049   5    16438    3.04   1.00 (0.94, 1.05)
  6-12 months        130187              21              64563    3.25   32686   7    16224    4.31   1.33 (1.26, 1.39)
  \> 1 year          127529              200             612536   3.27   32063   72   155208   4.64   1.42 (1.36, 1.48)

\*IRR (incidence rate ratio): herpes zoster vs. non-herpes zoster (95% CI)

†Incidence rate: per 10000 person-years.

\*\* Because no subject developed pyogenic liver abscesses among the herpes zoster group aged 20-39 years, subjects aged 20-39 years and aged 40-64 years were merged into subjects aged 20-64 years.

                                        Crude   Adjusted†             
  ------------------------------------- ------- -------------- ------ --------------
  Sex (male *vs.* female)               1.39    (1.12, 1.73)   1.41   (1.13, 1.75)
  Age (per one year)                    1.04    (1.03, 1.05)   1.03   (1.02, 1.04)
  Baseline comorbidities (yes vs. no)                                 
  Herpes zoster                         1.38    (1.07, 1.77)   1.34   (1.05, 1.72)
  Alcohol-related diseases              1.69    (0.95, 3.00)   \-     \-
  Biliary stones                        4.38    (3.13, 6.12)   2.87   (2.03, 4.06)
  Chronic kidney diseases               4.08    (2.73, 6.09)   2.41   (1.60, 3.63)
  Chronic liver diseases                1.82    (1.41, 2.34)   1.31   (1.01, 1.71)
  Cancers                               2.04    (1.30, 3.21)   1.60   (1.02, 2.53)
  Diabetes mellitus                     2.57    (2.04, 3.24)   1.66   (1.30, 2.12)

†Controlling for sex, age, biliary stones, chronic kidney diseases, chronic liver diseases, cancers, and diabetes mellitus.

4. Discussion {#Sec11}
=============

Pyogenic liver abscesses are defined as a common health problem in Taiwan society, with the incidence rate being higher than those in western society. According to the results of select studies, the annual incidence rate of pyogenic liver abscesses in Canada, United States and Denmark was only 2.3 × 10^-6^, 3.6 × 10^-6^ and 1.1 × 10^-6^ in 2003, 2005, and 2006 respectively, but in Taiwan it was 17.5 × 10^-6^ in 2004.\[[@CR14]-[@CR16]\] However, large-scale populationbased studies, which have been conducted to explore the relationship between herpes zoster and subsequent pyogenic liver abscesses, have thus far been few. In our study, we found that the adjusted HR of pyogenic liver abscesses was 1.34 (95% CI 1.05, 1.72), which is similar to other risk factors. Sex (in this case male) (adjusted HR 1.41, 95% CI 1.13, 1.75), age (per one year, adjusted HR 1.03, 95% CI 1.02, 1.04), biliary stones (adjusted HR 2.87, 95% CI 2.03, 4.06), chronic kidney diseases (adjusted HR 2.41, 95% CI 1.60, 3.63), chronic liver diseases (adjusted HR 1.31, 95% CI 1.01, 1.71), cancers (adjusted HR 1.60, 95% CI 1.02, 2.53), and diabetes mellitus (adjusted HR 1.66, 95% CI 1.30, 2.12) were also significantly associated with pyogenic liver abscesses.

Before the 1980s, the predominant cause of pyogenic liver abscesses was Klebsiella pneumoniae infection in Asian countries and areas\[[@CR17]-[@CR21]\]. According to our knowledge, Klebsiella pneumoniae infections are commonly associated to diabetes mellitus. Diabetes mellitus, which can decrease chemotaxis and phagocytosis and increase the susceptibility of bacterial infections to affect neutrophil functions, has been signaled as the strongest risk factor for liver abscesses in Taiwan.\[[@CR22], [@CR23]\] The condition of neutrophil dysfunction can be found in chronic kidney disease patients, especially the end stage of renal disease with dialysis population, which have a higher risk of infection.\[[@CR15], [@CR24]\] Several studies have reported that underlying chronic biliary diseases were the major cause of pyogenic liver abscesses.\[[@CR15], [@CR24]\] The bacteria might remain in the biliary tract and exacerbate the infection in patients with chronic biliary diseases. Kang and Hwang found that the incidence rate of gastroenterological cancers was higher in aged patients (\>65 years) as was the incidence of pyogenic liver abscesses.\[[@CR25]\] Hepatocellular carcinoma is associated to pyogenic liver abscesses in patients, especially in older patients. 65 years or older has been found to be one of the independent risk factors for pyogenic liver abscesses.\[[@CR25]-[@CR27]\]

Herpes zoster results from the reactivation of the latent varicella- zoster virus. The incidence of herpes zoster usually increases with age and other immune-compromised conditions, such as diabetes mellitus, chronic kidney diseases, and so on. Another factor is that cellular immunity is also decreased in advanced age individuals.\[[@CR28]\] Diabetes mellitus and chronic kidney diseases may result in a compromised immune system and neutrophil dysfunction, so these conditions may be risk factors of infectious diseases.\[[@CR29]-[@CR31]\]

In our study, we supposed that the mechanisms underlying the association between herpes and subsequent pyogenic liver abscesses may be complicated. First, the varicella-zoster virus possibly affects various liver tissues *via* neural, hematologic, or extrinsic spread. Second, it is possible that the reactivation of the varicella-zoster virus triggers some immunologic mechanisms, such as compromising cellular immunity and creating neutrophil dysfunction, which may later lead to pyogenic liver abscesses. Third, the initiation of emergence of herpes zoster and pyogenic liver abscesses could be the result of any dysfunction of the host's immunity, which is tasked with keeping the latent varicella-zoster virus under control and maintaining the healthy condition of the liver. Fourth, both herpes zoster and pyogenic liver abscesses could be associated with similar comorbidities or risk factors such as increased age and disorders which decrease the immune competency of an individual. The latter includes conditions such as diabetes mellitus, chronic renal diseases, chronic liver diseases, malignancies, *etc*. Hence, patients who have these underlying conditions will therefore be expected to develop herpes zoster or pyogenic liver abscesses. This could partially explain the biological plausibility of the observed association between herpes zoster and pyogenic liver abscess seen in this study.

Having said all of that, there are some limitations to our study. First, several studies have obtained their diagnoses through a standardized clinical procedure but our study obtained diagnoses of herpes zoster and pyogenic liver abscesses dependent upon ICD-9 codes. The diagnosis accuracy of herpes zoster pyogenic liver abscess and other comorbidities studied based on the IDC 9 codes has been thoroughly discussed in previous studies.\[[@CR32]-[@CR37]\] Second, some patients with herpes zoster may not go for medical help. This small percentage of individuals with herpes zoster who do not go for medical help would be erroneously categorized as non-herpes zoster. Third, due to the natural limitation of the national insurance database used in our study, there was no record of the severity of herpes zoster and pyogenic liver abscesses, nor the duration of other risk factors. In addition, there is no information available about the treatment of these risk factors and how that would impact the risk of either herpes zoster or pyogenic liver abscesses.

Nevertheless, we have concluded that patients with herpes zoster are associated with an increased hazard of developing pyogenic liver abscesses. The findings in our study suggest that a patient's hepatic condition should be cared for after they are diagnosed with herpes zoster.
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